Home Cart Sign in  
Chemical Structure| 88889-14-9 Chemical Structure| 88889-14-9

Structure of Fosinopril sodium
CAS No.: 88889-14-9

Chemical Structure| 88889-14-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fosinopril (sodium) is a prodrug of an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and chronic heart failure.

Synonyms: SQ28555; Fosinopril(sodium salt); Tensocardil

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fosinopril sodium

CAS No. :88889-14-9
Formula : C30H45NNaO7P
M.W : 585.64
SMILES Code : O=C([C@H]1N(C(C[P@@](CCCCC2=CC=CC=C2)(O[C@H](OC(CC)=O)C(C)C)=O)=O)C[C@H](C3CCCCC3)C1)[O-].[Na+]
Synonyms :
SQ28555; Fosinopril(sodium salt); Tensocardil
MDL No. :MFCD00865785

Safety of Fosinopril sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • ACE

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice Acute myocardial infarction model Intragastric administration 10 mg/kg Once daily for 7 days To evaluate the protective effect of Fosinopril on cardiac function in mice with acute myocardial infarction, the results showed that Fosinopril significantly improved cardiac function parameters (LVEDd, LVEDs, EF, and FS) Chin Med. 2023 Mar 17;18(1):29
Spontaneously hypertensive rats (SHR) Spontaneously hypertensive rat model Oral 2.5 mg/kg Once daily for 12 weeks To evaluate the antihypertensive effect of Fosinopril sodium in SHR, results showed significant reductions in systolic, diastolic, and mean blood pressures after single and long-term administration. Front Pharmacol. 2019 Apr 30;10:403
Sprague Dawley (SD) rats Chronic heart failure (CHF) rat model Oral 4.67 mg/kg Once daily for 28 and 60 days To evaluate the effect of Fosinopril sodium on heart function and renal fibrosis in CHF rats. Results showed that Fosinopril sodium improved heart function parameters (e.g., EF and FS) and reduced the expression of renal fibrosis-related indicators (e.g., CTGF and α-SMA). Front Pharmacol. 2019 Oct 23;10:1267

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.71mL

0.34mL

0.17mL

8.54mL

1.71mL

0.85mL

17.08mL

3.42mL

1.71mL

References

 

Historical Records

Categories